Press releases

EVOLVE trial to evaluate Company's fourth-generation SYNERGY™ drug-eluting coronary stent

Company now offers pain specialists the most comprehensive portfolio of SCS percutaneous leads

Company to participate in the August 5th conference in New York; live webcast and replay will be available

Company expands market-leading family of neurovascular stents

"I am proud of the way the organization executed in a number of key areas during the quarter," said Ray Elliott, President and CEO